olmesartan medoxomil has been researched along with Pregnancy in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujimori, I; Ikeda, T; Ishizuka, T; Izumi, T; Kato, M; Kubota, K; Kurihara, A; Noji-Sakikawa, C; Okazaki, O; Saito, M; Yoshigae, Y | 1 |
| Axt-Fliedner, R; Enzensberger, C; Eskef, K; Faas, D; Schwarze, A | 1 |
| Fukamizu, A; Hashimoto, M; Ishida, J; Ishimaru, T; Kunita, S; Matsukura, T; Nakamura, A; Nakamura, S; Sugiyama, F; Yagami, K | 1 |
| Celentano, C; di Vera, E; Gallo, DP; Iannicco, A; Liberati, M; Prefumo, F | 1 |
1 review(s) available for olmesartan medoxomil and Pregnancy
| Article | Year |
|---|---|
Course and outcome of pregnancy after maternal exposure to angiotensin-II-receptor blockers--case report and review of the literature.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Breech Presentation; Cesarean Section; Drug Substitution; Female; Follow-Up Studies; Humans; Hypertension; Imidazoles; Infant; Infant, Newborn; Kidney; Oligohydramnios; Olmesartan Medoxomil; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, First; Tetrazoles; Ultrasonography, Prenatal | 2012 |
4 other study(ies) available for olmesartan medoxomil and Pregnancy
| Article | Year |
|---|---|
Did Dr. & nurse fail notify pregnant Pt. to D/C Benicar? Mobile OB-GYN, PC. v. Baggett, 2009-AL-0615.006 (6/12/2009)-AL.
Topics: Alabama; Antihypertensive Agents; Cause of Death; Female; Fetal Distress; Homicide; Humans; Imidazoles; Infant, Newborn; Informed Consent; Obstetrics; Olmesartan Medoxomil; Patient Education as Topic; Pregnancy; Tetrazoles | 2009 |
Human carboxymethylenebutenolidase as a bioactivating hydrolase of olmesartan medoxomil in liver and intestine.
Topics: Amino Acid Sequence; Angiotensin II Type 1 Receptor Blockers; Biotransformation; Carboxylic Ester Hydrolases; Cell Line; Cytosol; DNA Primers; Enzyme Inhibitors; Female; Humans; Imidazoles; In Vitro Techniques; Intestines; Kinetics; Liver; Male; Molecular Sequence Data; Mutagenesis, Site-Directed; Olmesartan Medoxomil; Pregnancy; Prodrugs; Recombinant Proteins; RNA, Messenger; Sequence Homology, Amino Acid; Tetrazoles; Tissue Distribution | 2010 |
Short-term suppression of the renin-angiotensin system in mice associated with hypertension during pregnancy.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Female; Fetal Growth Retardation; Hypertension, Pregnancy-Induced; Imidazoles; Male; Mice; Mice, Inbred C57BL; Olmesartan Medoxomil; Placenta; Pregnancy; Renin-Angiotensin System; Tetrazoles; Time Factors; Ventricular Remodeling | 2012 |
Reversible acute fetal renal failure due to maternal exposure to angiotensin receptor blocker.
Topics: Angiotensin II Type 1 Receptor Blockers; Diuretics; Female; Fetal Diseases; Furosemide; Gestational Age; Humans; Imidazoles; Infant, Newborn; Male; Maternal Exposure; Oligohydramnios; Olmesartan Medoxomil; Pregnancy; Prenatal Diagnosis; Recovery of Function; Renal Insufficiency; Tetrazoles; Treatment Outcome | 2008 |